Member Info for BabyHuey

Well that's a sad little makey up post about Mandy, there is a clue in her job title, investor relations. Why would she release commercially sensitive information to some random clown. Grow up. What's wrong with you people that you make this rubbish up, are you that bored?

GDWK, ever hear of the Data Protection Act? secondly if you're a shareholder in NCYT try asking someone there. Just not Mandy, she is investor relations, it's not her job. See all those posts on here claiming to be replies from Mandy, all fake, crazy I know.

"A lot is happening? What? The company have told us absolutely nothing in this regard so where is this info coming from?"

They've told shareholders what they are obliged too, and other info is available.

Novacyt's problems of their own making are, too long focused on Covid, neglected non-covid portfolio, hired the wrong senior people

Follow on problems are, revenue drop, overstaffed, no strategy, bad company structure.

And the dispute, not necessarily a problem of their making.

What they've done is retire a load of products, make redundancies, started to make changes to the BoD. That's all info avail publicly.

What's left is find a new leadership, which will bring a new strategy and a focus which will (or should) fix the company culture and drive up revenue and of course the SP.

So I'm taking the relocation of the HO to the Primer Design site as a sign that the CEO and BoD issues are about to be fixed.

PI, the shares I didn't sell 3 mths ago are getting battered. There is no money in the market and less every day, it's Christmas so trading is light, and everyone is expecting bad news for 2023. So that's the market for everyone atm.

NCYT is now changing, things are moving, Q1 and/or Q2 will see a lot happening.

Back in July (I think, or earlier) I said it would take 4-6 Qs to turn it around, that's what happening.

Seriously, ignore the clowns here, there's better info available.

it's not PI, really it's not.

"Higher management (now departed CCO for example) had little post-Covid actions/plans. "

was the quote........

He actually left NCYT back in August, I think, he was gone beginning of Sept defo. Got a mention on glassdoor back early Sept.

at least wait for the new CEO, with the BoD moving to the coast surely it is at least a sign that some directors will change.

Not defending DA but advertising would be a marketing role, which NCYT has a director for plus a senior head in every vertical who would/should have a budget.

I had a Minder binge on awhile back, after I finished Sharpe

Now…where is that CEO?
Winchester at the moment

Interview and article on building Primer Design into a global multi-million pound company from a £30k start-up.

https://futureworlds.com/mentors-jim-wicks/

“We were lucky enough to be able to use a small amount of lab space at the University and, paying ourselves very little, we built our own website and designed our first product,” he says. Jim and Rob approached researchers from many universities who had an interest in PCR technology and persuaded them to buy enough of the product to help the business to make a small profit in its first year, which they then reinvested. “We repeated the reinvestment process over the next 15 years, which meant that we never needed to take any further investment as a business, enabling the business to grow organically,”

For the longest time I got the impression that the current BoD and now ex-CEO didn't have the stomach for it. Never a positive public comment let alone spending money on a PR agency and/or getting positive articles published, nor any noticeable lobbying. The BoD was strengthened with people from a corporate background in anticipation of rapid growth, the opposite happened and people like that don't have the skills for running a small business or fighting court cases.

TL/DR
The new CEO might show an interest, the last one didn't

As for the drop crl, don't forget that while still holding last weeks gains todays drop is amplified by an illiquid market, at a traditionally illiquid time of year, likely right before the mother of all recessions.

Only two reasons to move the BoD to Southampton. Either

A) Camberley is closing, everyone is being made redundant and the lease getting disposed off.
B) Camberley is staying open and there's another reason to move the BoD to Primer Design.

If it's A) it's a big decision for an 'Acting' CEO to make, and it's a lousy one to have to implement, so why not leave it for the next CEO.

If it's B) it could be a few different reasons, but they all look positive. My mad hope is that the ex-founder of Primer Design Jim Wicks has negotiated a reverse takeover by YouSeq and will bring some new directors with him, some momentum to the dispute, and some leadership. That's all I want for Christmas.

crl, did you know the Primer Design office in Southampton is now the Novacyt Group Head Office.

Have a think about all the possible reasons for the move, and if you can think of a bad one let me know.

Crl, thing to note is why the drop was so little, the momentum has changed, there will be profit taking but the fact that it's only dropped 7% says lots.

There appears to be a new strategy in place which will fixed all or some of the problems of NCYT, the toxic culture, a new knowledgeable CEO, changes to the board room, momentum in defending dispute, and some M&A .

Me, I'm happy, light at the end of the tunnel, clawed back about 300 in losses despite the drop, hoping on 1.50 SP before the end of Q1

NCYT Head Office moved to Eastleigh sometime in November after DA left does anyone know anything about this?

Thanks again Larry but the Question is
"To put it bluntly will customers buy EASY/ADVANCED tests instead of STANDARD or is it likely that rev will drop further"
I'm a shareholder I only care about revenue and SP, all you or anyone else says is they have hundreds of tests, OK, but will customers want them or do they want STANDARD and why?

Just to point out NCYT is a commercial company not part of the NHS, has anyone actually thought about demand, cost, margin, GP?
It's lovely that everyone wants NCYT to jump on everything yesterday, MonkeyPox, Streph A, and every other wee virus that gets mentioned in the Daily Mail, but as a shareholder I want to see a profit not this caped crusader rubbish.

Thanks Larry, but it's the STANDARD tests that I wanted to know about, why are customers using STANDARD and not EASY/ADVANCED, will they be happy STANDARD is no longer available, is it a price or tech reason.

To put it bluntly will customers buy EASY/ADVANCED tests instead of STANDARD or is it likely that rev will drop further